Japan Pharmaceutical Manufacturers Association
E555146
The Japan Pharmaceutical Manufacturers Association is a major industry organization representing research-based pharmaceutical companies in Japan and contributing to international regulatory harmonization and policy development.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Japan Pharmaceutical Manufacturers Association canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5932249 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Japan Pharmaceutical Manufacturers Association Context triple: [ICH, hasFoundingIndustryAssociation, Japan Pharmaceutical Manufacturers Association]
-
A.
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
-
B.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
C.
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
D.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
E.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Japan Pharmaceutical Manufacturers Association Target entity description: The Japan Pharmaceutical Manufacturers Association is a major industry organization representing research-based pharmaceutical companies in Japan and contributing to international regulatory harmonization and policy development.
-
A.
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
-
B.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
C.
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
D.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
E.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
- F. None of above. chosen
Statements (39)
| Predicate | Object |
|---|---|
| instanceOf |
industry association
ⓘ
non-profit organization ⓘ trade association ⓘ |
| abbreviation | JPMA NERFINISHED ⓘ |
| activity |
collection and publication of industry statistics
ⓘ
formulation of industry guidelines ⓘ participation in international conferences ⓘ policy proposals to government ⓘ promotion of ethical drug promotion practices ⓘ |
| aimsTo |
align Japanese regulations with international standards
ⓘ
ensure timely patient access to innovative medicines ⓘ support sustainable healthcare systems in Japan ⓘ |
| contributesTo |
global pharmaceutical policy discussions
ⓘ
international regulatory harmonization ⓘ pharmaceutical policy development in Japan ⓘ |
| country | Japan ⓘ |
| engagesIn |
dialogue with Japanese government authorities
ⓘ
dialogue with international regulatory agencies ⓘ international cooperation on pharmaceutical regulation ⓘ |
| field |
drug development
ⓘ
healthcare ⓘ pharmaceutical regulation ⓘ |
| focus |
biopharmaceuticals
ⓘ
innovative medicines ⓘ prescription pharmaceuticals ⓘ |
| languageOfOperation |
English
ⓘ
Japanese ⓘ |
| location | Tokyo ⓘ |
| memberOf | International Federation of Pharmaceutical Manufacturers & Associations NERFINISHED ⓘ |
| purpose |
improvement of public health
ⓘ
industry representation ⓘ policy advocacy ⓘ promotion of research-based pharmaceuticals ⓘ regulatory harmonization ⓘ |
| represents | research-based pharmaceutical companies in Japan ⓘ |
| sector | pharmaceutical industry ⓘ |
| worksWith |
Ministry of Health, Labour and Welfare of Japan
NERFINISHED
ⓘ
Pharmaceuticals and Medical Devices Agency NERFINISHED ⓘ international pharmaceutical industry associations ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Japan Pharmaceutical Manufacturers Association Description of subject: The Japan Pharmaceutical Manufacturers Association is a major industry organization representing research-based pharmaceutical companies in Japan and contributing to international regulatory harmonization and policy development.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.